| 二氮嗪预处理骨髓源性心肌干细胞移植治疗心肌梗死的实验研究 |
| |
| 引用本文： | 崔晓军,张剑凯,谭玉珍,谢华,郭金华,国海东,王存. 二氮嗪预处理骨髓源性心肌干细胞移植治疗心肌梗死的实验研究[J]. 中西医结合心脑血管病杂志, 2011, 9(4) |
| |
| 作者姓名： | 崔晓军 张剑凯 谭玉珍 谢华 郭金华 国海东 王存 |
| |
| 作者单位： | 1. 广东医学院基础医学院,524808
2. 复旦大学上海医学院 |
| |
| 基金项目： | 为广东省湛江市科技攻关计划项目 |
| |
| 摘 要： | 目的 探讨二氮嗪预处理骨髓源性心肌干细胞(MCSCs)移植治疗心肌梗死的机制及效果.方法 通过单细胞克隆培养技术,从雄性幼鼠骨髓间充质干细胞中筛选具有心肌特异分化潜能的MCSCs;将雌性大鼠心肌梗死模型随机分为对照组、MCSCs移植组、二氮嗪预处理MCSCs移植组;细胞移植后4 周,用M型超声心动图检测心功能恢复情况,心脏组织切片进行Masson染色,利用图像分析检测胶原纤维比率,用原位荧光杂交法标记心肌组织中Y染色体细胞,并检测其cTnT的表达.结果 二氮嗪预处理细胞移植组与MCSCs移植组相比,大鼠的心功能指数明显提高,胶原纤维比率明显减小,Y染色体阳性细胞数明显增多,差异均有统计学意义.结论 二氮嗪预处理MCSCs移植治疗心肌梗死,有利于移植细胞在受损心肌内的存活,并促进心功能恢复,其疗效优于单纯干细胞移植.
|
| 关 键 词： | 二氮嗪 骨髓源性心肌干细胞 心肌梗死 移植 |
Study on Transplantation of Marrow-derived Cardiac Stem Cells Pretreated with Diazoxide for Treatment of Myocardial Infarction |
| |
| Cui Xiaojun,Zhang Jiankai,Tan Yuzhen,et al. Study on Transplantation of Marrow-derived Cardiac Stem Cells Pretreated with Diazoxide for Treatment of Myocardial Infarction[J]. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, 2011, 9(4) |
| |
| Authors: | Cui Xiaojun Zhang Jiankai Tan Yuzhen et al |
| |
| Affiliation: | Cui Xiaojun,Zhang Jiankai,Tan Yuzhen,et al Department of Anatomy,Guangdong Medical College(Dongguan 524808) |
| |
| Abstract: | Objective To explore the effect of transplantation of marrow-derived cardiac stem cells(MCSCs) pretreated with diazoxide on cardiac function after myocardial infarction(MI).Methods MCSCs were selected from marrow mesenchymal stem cells of male rats with single-cell cloning culture.Thirty minutes after the establishment of acute myocardial infarction model of female rats,the rats were injected at the edge of infracted area with PBS,MCSCs,MCSCs pretreated with diazoxide respectively.Four weeks after MI,the ca... |
| |
| Keywords: | diazoxide mesenchymal stem cells myocardial infarction transplantation |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
